Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.0813 | 45 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.10534 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.14541 | 48 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.11571 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.40761 | 57 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.15402 | 45 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.14925 | 46 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.14002 | 48 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.17159 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.14833 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.59449 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.14423 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.27061 | 52 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.27142 | 52 |